Cargando…

The therapeutic and prognostic implications of molecular biomarkers in urothelial carcinoma

Urothelial cell carcinoma (UCC) of the bladder and upper urinary tract is a heterogeneous disease with distinct biologic features resulting in different clinical behaviors. Bladder cancer (BC) is classified into non-muscle invasive BC (NMIBC) and muscle invasive BC (MIBC). NMIBC is associated with h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Ho Won, Kim, Wun-Jae, Yun, Seok Joong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Review Article on Urothelial Carcinoma
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798786/ https://www.ncbi.nlm.nih.gov/pubmed/35117271 http://dx.doi.org/10.21037/tcr-20-1243

Ejemplares similares

Current status of the focused series “Urothelial Carcinoma”
por: Yuk, Hyeong Dong, et al.
Publicado: (2020)

Neoadjuvant chemotherapy for upper tract urothelial carcinoma
por: Kim, Do Kyung, et al.
Publicado: (2020)

The prognostic role of steroid hormone receptor signaling pathways in urothelial carcinoma
por: Nagata, Yujiro, et al.
Publicado: (2020)

Current perspectives on novel systemic therapeutic agents beyond immune checkpoint inhibition in metastatic urothelial carcinoma
por: Choi, Hoon, et al.
Publicado: (2020)

Nephron-sparing approaches in the management of upper tract urothelial carcinoma: indications and clinical outcomes
por: Ko, Young Hwii
Publicado: (2020)

Review of non-invasive urinary biomarkers in bladder cancer
por: Lee, Hyung-Ho, et al.
Publicado: (2020)

Variant histology in bladder cancer: diagnostic and clinical implications
por: Black, Anna J., et al.
Publicado: (2020)

Perioperative immunotherapy in muscle-invasive bladder cancer
por: Lee, Hyung Ho, et al.
Publicado: (2020)

Fibroblast Growth Factor Receptor 3 Mutation as a Prognostic Indicator in Patients with Urothelial Carcinoma: A Systematic Review and Meta-analysis
por: Khalid, Sidra, et al.
Publicado: (2020)

Role of immunotherapy in Bacillus Calmette-Guérin unresponsive: non-muscle invasive bladder cancer
por: Suh, Jungyo, et al.
Publicado: (2020)

Enfortumab Vedotin in Metastatic Urothelial Carcinoma: Survival and Safety in a European Multicenter Real-world Patient Cohort
por: Zschäbitz, Stefanie, et al.
Publicado: (2023)

The Association Between Renal Function Decline and the Incidence of Urothelial Carcinoma: A 16-year Retrospective Cohort Study in Taiwan
por: Chuang, Yung-Hsin, et al.
Publicado: (2021)

International Opinions on Grading of Urothelial Carcinoma: A Survey Among European Association of Urology and International Society of Urological Pathology Members
por: Beijert, Irene J., et al.
Publicado: (2023)

Location of Retroperitoneal Lymph Node Metastases in Upper Tract Urothelial Carcinoma: Results from a Prospective Lymph Node Mapping Study
por: Bobjer, Johannes, et al.
Publicado: (2023)

Survival and Long-term Effects of Kidney-sparing Surgery Versus Radical Nephroureterectomy on Kidney Function in Patients with Upper Urinary Tract Urothelial Carcinoma
por: Hendriks, Nora, et al.
Publicado: (2022)

Is a Single Nephrographic Phase Computed Tomography Sufficient for Detecting Urothelial Carcinoma in Patients with Visible Haematuria? A Prospective Paired Noninferiority Comparison
por: Galtung, Kristina F., et al.
Publicado: (2023)

Prognostic Value of Tumor Size in Patients with Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-analysis
por: Ma, Runzhuo, et al.
Publicado: (2022)

Site-specific Risk Stratification Models for Postoperative Recurrence and Survival Prediction in Patients with Upper Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy: Better Stratification for Adjuvant Therapy
por: Miyake, Makito, et al.
Publicado: (2022)

Ureteroscopic biopsy of upper tract urothelial carcinoma and role of urinary biomarkers
por: Smentkowski, Katherine E., et al.
Publicado: (2020)

Postoperative Chemotherapy Bladder Instillation After Radical Nephroureterectomy: Results of a European Survey from the Young Academic Urologist Urothelial Cancer Group
por: Dobé, Tom-Régis, et al.
Publicado: (2020)

Real-world Treatment Patterns and Overall Survival in Locally Advanced and Metastatic Urothelial Tract Cancer Patients Treated with Chemotherapy in Denmark in the Preimmunotherapy Era: A Nationwide, Population-based Study
por: Omland, Lise H., et al.
Publicado: (2020)

Outcomes of endoscopic management of upper tract urothelial carcinoma
por: Knoedler, John J.
Publicado: (2020)

Bladder Recurrence Following Upper Tract Surgery for Urothelial Carcinoma: A Contemporary Review of Risk Factors and Management Strategies
por: Mertens, Laura S., et al.
Publicado: (2023)

An editorial comment for the special series “Upper-Tract Urothelial Carcinoma: Current State and Future Directions”
por: Knoedler, John J., et al.
Publicado: (2020)

Epidemiology, clinical presentation, and evaluation of upper-tract urothelial carcinoma
por: Petros, Firas G.
Publicado: (2020)

Endoscopic management of upper tract urothelial carcinoma—tips and tricks
por: Shvero, Asaf, et al.
Publicado: (2020)

Bladder tumor recurrence after urothelial carcinoma of the upper urinary tract
por: Lonergan, Peter E., et al.
Publicado: (2020)

The role of lymphadenectomy at the time of radical nephroureterectomy for upper tract urothelial carcinoma
por: Goltzman, Michael E., et al.
Publicado: (2020)

Future strategies to enhance kidney preservation in upper urinary tract urothelial carcinoma
por: Metcalf, Meredith, et al.
Publicado: (2020)

The Treatment of Carcinoma of the Lung
por: Wood, Duncan
Publicado: (1936)

Bronchoscopic Diagnosis of Carcinoma of the Lung
por: Scarff, Gordon
Publicado: (1936)

Primary Carcinoma of the Lung Radiologically Considered
por: Bush, Gilbert B.
Publicado: (1936)

Nasopharyngeal carcinoma – Improving cure with technology and clinical trials
por: Tsang, Raymond K.
Publicado: (2020)

Perioperative chemotherapy in the management of high risk upper tract urothelial cancers
por: Kaag, Matthew G.
Publicado: (2020)

Repeated exposure to fractional CO(2) laser delays squamous cell carcinoma formation and prevents clinical and subclinical photodamage visualized by line‐field confocal optical coherence tomography and histology
por: Olesen, Uffe H., et al.
Publicado: (2022)

Telehealth in Uro-oncology Beyond the Pandemic: Toll or Lifesaver?
por: Rodler, Severin, et al.
Publicado: (2020)

Prediction of Metastatic Patterns in Bladder Cancer: Spatiotemporal Progression and Development of a Novel, Web-based Platform for Clinical Utility
por: Mason, Jeremy, et al.
Publicado: (2021)

Intraoperative Mitomycin C Bladder Instillation During Radical Nephroureterectomy Is Feasible and Safe
por: Nadler, Naomi, et al.
Publicado: (2021)

Comparative Outcomes of Primary Versus Recurrent High-risk Non–muscle-invasive and Primary Versus Secondary Muscle-invasive Bladder Cancer After Radical Cystectomy: Results from a Retrospective Multicenter Study
por: Grossmann, Nico C., et al.
Publicado: (2022)

STAG2 Protein Expression in Non–muscle-invasive Bladder Cancer: Associations with Sex, Genomic and Transcriptomic Changes, and Clinical Outcomes
por: Gordon, Naheema S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t1k59vh6o11savnp97lvlpau19